TRANSDERMAL HORMONE REPLACEMENT THERAPIES
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via transdermal HRT delivery systems.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
03.12.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via transdermal HRT delivery systems. |
---|---|
Bibliography: | Application Number: EP20130741053 |